Drawing for MEDIDATA RAVEX

USPTO serial 86979160

MEDIDATA RAVEX

Reviewed by CopyMark Law Group

Reg. 4994931Status 702Renewal
Filing date
Status date
Registration date
Jul 5, 2016
Examiner
FOSDICK, GEOFFREY A
Law office
TMO LAW OFFICE 111

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with MEDIDATA RAVEX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $299*

Plus Government fees of $850

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jordan A. LaVine

Jordan A. LaVine Flaster Greenberg P C100 Front Street. Suite 100Conshohocken, PA 19428UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
042Software as a service (saas) solutions featuring software for capturing, managing and reporting data and information in the fields of medical clinical trials and medical research, for designing, managing, and executing medical clinical trials and medical research and medical clinical trial and medical research protocols, for forecasting and benchmarking budgets and costs in medical clinical trials and medical research, for medical coding in medical clinical trials and medical research, for the collection of information and data in medical clinical trials and medical research, for evaluating and measuring the performance and results of medical clinical trials and medical research, for capturing, managing, organizing and reporting the results of medical clinical trials and medical research, for monitoring and events capture in the nature of gathering and organizing information and data generated in medical clinical trials and medical research, for medical clinical trial and medial research user and learning management, for medical clinical trial and medical research operational reporting and analytics, and for medical clinical trial and medical research patient randomization and supply management; providing temporary use of online non-downloadable computer software for capturing, managing and reporting data and information in the fields of medical clinical trials and medical research, for designing, managing, and executing medical clinical trials and medical research and medical clinical trial and medical research protocols, for forecasting and benchmarking budgets and costs in medical clinical trials and medical research, for medical coding in medical clinical trials and medical research, for the collection of information and data in medical clinical trials and medical research, for evaluating and measuring the performance and results of medical clinical trials and medical research, for managing, organizing and reporting the results of medical clinical trials and medical research, for monitoring and events capture in the nature of gathering and organizing information and data generated in medical clinical trials and medical research, for medical clinical trial and medical research user and learning management, for medical clinical trial and medical research operational reporting and analytics, and for medical clinical trial and medical research patient randomization and supply managementACTIVESep 5, 2015

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 5, 2025REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Nov 6, 2021NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Nov 6, 2021C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Nov 6, 2021APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Aug 3, 2021E815TEAS SECTION 8 & 15 RECEIVED—
Jul 5, 2021REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jul 5, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 2, 2016SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Jun 1, 2016CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
May 25, 2016SUPCSTATEMENT OF USE PROCESSING COMPLETE—
May 25, 2016DPCCDIVISIONAL PROCESSING COMPLETE—
May 24, 2016AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Apr 13, 2016IUAFUSE AMENDMENT FILED—
Apr 13, 2016DRRRDIVISIONAL REQUEST RECEIVED—
Apr 13, 2016EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Apr 13, 2016ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Oct 13, 2015NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 18, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 18, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 29, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 16, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jul 16, 2015ALIEASSIGNED TO LIE—
Jul 1, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 24, 2015DOCKASSIGNED TO EXAMINER—
May 19, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 14, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance